Skip to main content
Caplight Logo









ExThera Medical

ExThera Medical

Private
Martinez, CaliforniaHealthcare & Life Scienceshttps://extheramedical.com/

Last Round

Grant

Feb 24, 2025

Total Funding Raised

$40.98M

Company Overview

ExThera Medical is a medical device company that develops and commercializes extracorporeal blood filtration devices designed to treat bloodstream infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

blood filterhemoperfusionextracorporeal blood filtrationsepsis treatmentblood purificationpathogen removalbloodstream infectionbiomimetic technologysepsis filteradjunct therapydrug-resistant pathogenscritical care devicecirculating tumor cell removalmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ExThera Medical Comparables

Compare ExThera Medical with similar companies based on industry and business-model similarity.

ExThera Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Efferon
86%
PATH EX, Inc.
85%
Hemotune AG
84%

ExThera Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 24, 2025
StrategicDec 1, 2023
Series CMar 17, 2021
Series BJun 2, 2016
Convertible DebtOct 7, 2014

Key People

Founding team and executive leadership

Erin Borger

CEO

Executive Team

ExThera Medical Investors

Notable investors and investment history

ExThera Medical investors
InvestorRounds
Fresenius Medical Care VenturesSeries B
Quadrant ManagementStrategic
Medical Technology Enterprise ConsortiumGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 19, 2026

    Monthly visitors grew 41% MoM, from 933 to 1.3K.

  • Feb 24, 2025

    $235K grant from Medical Technology Enterprise Consortium

ExThera Medical Filings

Explore SEC and related filing metadata, where available.

ExThera Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ExThera Medical's valuation, stock price, and market status.

Is ExThera Medical a public or private company?

ExThera Medical is a private company.

What is the current stock price of ExThera Medical?

ExThera Medical is a private company with no public stock price. No recent secondary market data is available.

How much is ExThera Medical worth (valuation)?

Valuation information for ExThera Medical is not publicly available.

Can I buy ExThera Medical stock?

ExThera Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ExThera Medical's last funding round?

ExThera Medical's most recent funding round was Grant on February 24, 2025.

Who are the main investors in ExThera Medical?

Key investors in ExThera Medical include Fresenius Medical Care Ventures, Quadrant Management.

Will ExThera Medical IPO soon?

No public IPO plans have been announced for ExThera Medical.

How can I track ExThera Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ExThera Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMartinez, California
Employee Range30
Year Founded2007
Last FundingFeb 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?